• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT

BIOTRON LIMITED - Announcements

0.00% ! 0.3¢
Market Cap $3.318M  !

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



BIT BIT225 Phase 2 HIV-1 Clinical Trial Fully RecruitedPRICE SENSITIVE27/07/17 download Created with Sketch. 36.52KB
BIT Appendix 3B19/07/17 download Created with Sketch. 99.3KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE13/07/17 download Created with Sketch. 87.48KB
BIT Change of Director's Interest Notice05/07/17 download Created with Sketch. 80.3KB
BIT Change of Director's Interest Notices28/06/17 download Created with Sketch. 105.95KB
BIT Change of Director's Interest Notice27/06/17 download Created with Sketch. 80.14KB
BIT New Issue Oversubscribed23/06/17 download Created with Sketch. 31.25KB
BIT Change of Director's Interest Notice22/06/17 download Created with Sketch. 80.02KB
BIT Change of Director's Interest Notice19/06/17 download Created with Sketch. 45.35KB
BIT BIT225 Phase 2 HIV-1 Clinical Trial UpdatePRICE SENSITIVE15/06/17 download Created with Sketch. 45.74KB
BIT Advisor appointed to advance commercialisation in China09/06/17 download Created with Sketch. 36.26KB
BIT ProspectusPRICE SENSITIVE25/05/17 download Created with Sketch. 170.89KB
BIT Renounceable IssuePRICE SENSITIVE25/05/17 download Created with Sketch. 2.02MB
BIT Appendix 3B25/05/17 download Created with Sketch. 130.14KB
BIT The Need for Drugs Targeting HIV-1 in Macophages01/05/17 download Created with Sketch. 64.38KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE20/04/17 download Created with Sketch. 87.41KB
BIT Update on Progress of BIT225 Phase 2 HIV-1 Clinical TrialPRICE SENSITIVE11/04/17 download Created with Sketch. 40.14KB
BIT Letter to Shareholders27/02/17 download Created with Sketch. 231.2KB
BIT Half Yearly Report and AccountsPRICE SENSITIVE24/02/17 download Created with Sketch. 256.06KB
BIT $1.6 Million R&D Tax Rebate ReceivedPRICE SENSITIVE13/02/17 download Created with Sketch. 32.75KB
BIT Commencement of BIT225 Phase 2 HIV-1 Clinical TrialPRICE SENSITIVE13/02/17 download Created with Sketch. 41.94KB
BIT BIT225 Accelerates HIV-1 Virus ReductionPRICE SENSITIVE06/02/17 download Created with Sketch. 36.23KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE16/01/17 download Created with Sketch. 82.15KB
BIT Corrected Presentation to Biotech Showcase 201713/01/17 download Created with Sketch. 3.6MB
BIT Biotron Presents at Biotech Showcase 201713/01/17 download Created with Sketch. 3.47MB
BIT Results of Meeting22/11/16 download Created with Sketch. 31.86KB
BIT AGM Presentation22/11/16 download Created with Sketch. 1.66MB
BIT Annual report and Notice of Annual General Meeting-BIT.AX 17/10/16 download Created with Sketch. 894.71KB
BIT Appendix 4C - quarterly-BIT.AX PRICE SENSITIVE17/10/16 download Created with Sketch. 82.17KB
BIT Change of Director's Interest Notice-BIT.AX 05/10/16 download Created with Sketch. 41.02KB
BIT Appendix 3B-BIT.AX 05/10/16 download Created with Sketch. 111.3KB
BIT Clarification Statement-BIT.AX 05/09/16 download Created with Sketch. 43.93KB
BIT Option Expiry Notice-BIT.AX 02/09/16 download Created with Sketch. 106.54KB
BIT Zika Virus Program Update-BIT.AX PRICE SENSITIVE22/08/16 download Created with Sketch. 79.6KB
BIT Full Year Statutory Accounts-BIT.AX PRICE SENSITIVE05/08/16 download Created with Sketch. 428.34KB
BIT Appendix 4G and Corporate Governance Statement-BIT.AX 05/08/16 download Created with Sketch. 239.8KB
BIT Appendix 3B-BIT.AX 15/07/16 download Created with Sketch. 59.08KB
BIT Appendix 4C - quarterly-BIT.AX PRICE SENSITIVE08/07/16 download Created with Sketch. 22.67KB
BIT Appendix 3B-BIT.AX 07/07/16 download Created with Sketch. 59.09KB
BIT Biotron compounds demonstrate activity against Zika virus-BIT.AX PRICE SENSITIVE23/05/16 download Created with Sketch. 98.76KB
BIT Presentation at Biotech Invest 2016-BIT.AX 04/05/16 download Created with Sketch. 1.12MB
BIT $1.5 Million R&D Tax Rebate-BIT.AX PRICE SENSITIVE20/04/16 download Created with Sketch. 34.13KB
BIT Appendix 4C - quarterly-BIT.AX PRICE SENSITIVE20/04/16 download Created with Sketch. 22.69KB
BIT Letter to Shareholders-BIT.AX 12/04/16 download Created with Sketch. 239.67KB
BIT Phase 2 Hepatitis C Trial SuccessPRICE SENSITIVE17/03/16 download Created with Sketch. 26.86KB
BIT Half Yearly Report and AccountsPRICE SENSITIVE26/02/16 download Created with Sketch. 107.47KB
BIT BIT225 MAY HAVE A BROADER ROLE IN LIMITING HIV-1 INFECTIONPRICE SENSITIVE18/02/16 download Created with Sketch. 36.42KB
BIT BIOTRON COMPOUNDS TESTED FOR ACTIVITY AGAINST ZIKA VIRUSPRICE SENSITIVE16/02/16 download Created with Sketch. 22.68KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE15/01/16 download Created with Sketch. 22.71KB
BIT Appendix 3B15/01/16 download Created with Sketch. 59.08KB
BIT BIOTRON LIMITED PRESENTS AT BIOTECH SHOWCASE 201612/01/16 download Created with Sketch. 3.12MB
BIT POTENTIAL ERADICATION OF HIV RESEVOIRS DATA PUBLISHED03/12/15 download Created with Sketch. 25.4KB
BIT Grant of Options and Appendices 3B and 3Y25/11/15 download Created with Sketch. 111.57KB
BIT Results of Meeting24/11/15 download Created with Sketch. 29.07KB
BIT AGM Presentation24/11/15 download Created with Sketch. 1.91MB
BIT Appendix 4C - quarterlyPRICE SENSITIVE22/10/15 download Created with Sketch. 37.74KB
BIT Annual Report, Governance Statement and Notice of AGM21/10/15 download Created with Sketch. 757.9KB
BIT Change of Director's Interest Notice15/10/15 download Created with Sketch. 38.57KB
BIT Presentation to Investors06/10/15 download Created with Sketch. 524.59KB
BIT Letter to Shareholders06/10/15 download Created with Sketch. 139.7KB
BIT INTERIM HCV GENOTYPE 3 DATA FROM BIT225-008 STUDYPRICE SENSITIVE30/09/15 download Created with Sketch. 31.61KB
BIT Annual Report to ShareholdersPRICE SENSITIVE28/08/15 download Created with Sketch. 363.33KB
BIT Investor Presentation20/08/15 download Created with Sketch. 1.06MB
BIT Letter to Shareholders28/07/15 download Created with Sketch. 247.39KB
BIT Cash Flow ReportPRICE SENSITIVE27/07/15 download Created with Sketch. 47.21KB
BIT SPP Completed. Appendices 3B and 3Y.15/07/15 download Created with Sketch. 157.81KB
BIT Independent review supports development of BIT225PRICE SENSITIVE06/07/15 download Created with Sketch. 25.16KB
BIT Appendix 3B03/07/15 download Created with Sketch. 111.39KB
BIT Appendix 3B23/06/15 download Created with Sketch. 121.63KB
BIT Share Purchase Plan and Placement to Raise $4.0 MillionPRICE SENSITIVE18/06/15 download Created with Sketch. 339.09KB
BIT Trading HaltPRICE SENSITIVE16/06/15 download Created with Sketch. 42.19KB
BIT Presentation to Investors28/05/15 download Created with Sketch. 1.78MB
BIT Appendix 4C - quarterlyPRICE SENSITIVE24/04/15 download Created with Sketch. 37.76KB
BIT R&D Tax IncentivePRICE SENSITIVE21/04/15 download Created with Sketch. 48.72KB
BIT Update on Phase 2 Trial and IND ProgressPRICE SENSITIVE17/04/15 download Created with Sketch. 40.79KB
BIT Change of Director's Interest Notice05/03/15 download Created with Sketch. 38.62KB
BIT Appendix 3B27/02/15 download Created with Sketch. 59.07KB
BIT Half Yearly Report and AccountsPRICE SENSITIVE27/02/15 download Created with Sketch. 112.08KB
BIT Response to ASX price queryPRICE SENSITIVE26/02/15 download Created with Sketch. 111.4KB
BIT Appendix 3B03/02/15 download Created with Sketch. 59.07KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE21/01/15 download Created with Sketch. 37.77KB
BIT BIOTRON LIMITED PRESENTS AT BIOTECH SHOWCASE 201513/01/15 download Created with Sketch. 39.26KB
BIT Response to ASX Price QueryPRICE SENSITIVE08/01/15 download Created with Sketch. 117.33KB
BIT Appendix 3B19/12/14 download Created with Sketch. 59.1KB
BIT Details of Share Registry Address10/12/14 download Created with Sketch. 18.99KB
BIT Presentation to Investors04/12/14 download Created with Sketch. 2.27MB
BIT Enrolment of Phase 2 Hepatitis C Trial of BIT225 CompletedPRICE SENSITIVE03/12/14 download Created with Sketch. 26.74KB
BIT Appendix 3B03/12/14 download Created with Sketch. 59.09KB
BIT Change of Director's Interest Notice20/11/14 download Created with Sketch. 39.09KB
BIT Results of Meeting13/11/14 download Created with Sketch. 28.54KB
BIT Chairman's Address to Shareholders13/11/14 download Created with Sketch. 2.59MB
BIT Change of Director's Interest Notice12/11/14 download Created with Sketch. 58.95KB
BIT Fully Underwritten Rights Issue Closes Oversubscribed05/11/14 download Created with Sketch. 84.35KB
BIT Appendix 4C - quarterlyPRICE SENSITIVE31/10/14 download Created with Sketch. 37.7KB
BIT Appendix 3B15/10/14 download Created with Sketch. 71.2KB
BIT Rights Issue ProspectusPRICE SENSITIVE15/10/14 download Created with Sketch. 1.69MB
BIT Fully Underwritten Rights Issue and Investor PresentationPRICE SENSITIVE15/10/14 download Created with Sketch. 2.31MB
BIT Annual Report and Notice of AGM14/10/14 download Created with Sketch. 584.46KB
BIT Trading haltPRICE SENSITIVE13/10/14 download Created with Sketch. 46.2KB
BIT BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS CPRICE SENSITIVE10/10/14 download Created with Sketch. 55.29KB
BIT BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
27/07/17PRICE SENSITIVE download Created with Sketch. 36.52KB
BIT Appendix 3B
19/07/17 download Created with Sketch. 99.3KB
BIT Appendix 4C - quarterly
13/07/17PRICE SENSITIVE download Created with Sketch. 87.48KB
BIT Change of Director's Interest Notice
05/07/17 download Created with Sketch. 80.3KB
BIT Change of Director's Interest Notices
28/06/17 download Created with Sketch. 105.95KB
BIT Change of Director's Interest Notice
27/06/17 download Created with Sketch. 80.14KB
BIT New Issue Oversubscribed
23/06/17 download Created with Sketch. 31.25KB
BIT Change of Director's Interest Notice
22/06/17 download Created with Sketch. 80.02KB
BIT Change of Director's Interest Notice
19/06/17 download Created with Sketch. 45.35KB
BIT BIT225 Phase 2 HIV-1 Clinical Trial Update
15/06/17PRICE SENSITIVE download Created with Sketch. 45.74KB
BIT Advisor appointed to advance commercialisation in China
09/06/17 download Created with Sketch. 36.26KB
BIT Prospectus
25/05/17PRICE SENSITIVE download Created with Sketch. 170.89KB
BIT Renounceable Issue
25/05/17PRICE SENSITIVE download Created with Sketch. 2.02MB
BIT Appendix 3B
25/05/17 download Created with Sketch. 130.14KB
BIT The Need for Drugs Targeting HIV-1 in Macophages
01/05/17 download Created with Sketch. 64.38KB
BIT Appendix 4C - quarterly
20/04/17PRICE SENSITIVE download Created with Sketch. 87.41KB
BIT Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
11/04/17PRICE SENSITIVE download Created with Sketch. 40.14KB
BIT Letter to Shareholders
27/02/17 download Created with Sketch. 231.2KB
BIT Half Yearly Report and Accounts
24/02/17PRICE SENSITIVE download Created with Sketch. 256.06KB
BIT $1.6 Million R&D Tax Rebate Received
13/02/17PRICE SENSITIVE download Created with Sketch. 32.75KB
BIT Commencement of BIT225 Phase 2 HIV-1 Clinical Trial
13/02/17PRICE SENSITIVE download Created with Sketch. 41.94KB
BIT BIT225 Accelerates HIV-1 Virus Reduction
06/02/17PRICE SENSITIVE download Created with Sketch. 36.23KB
BIT Appendix 4C - quarterly
16/01/17PRICE SENSITIVE download Created with Sketch. 82.15KB
BIT Corrected Presentation to Biotech Showcase 2017
13/01/17 download Created with Sketch. 3.6MB
BIT Biotron Presents at Biotech Showcase 2017
13/01/17 download Created with Sketch. 3.47MB
BIT Results of Meeting
22/11/16 download Created with Sketch. 31.86KB
BIT AGM Presentation
22/11/16 download Created with Sketch. 1.66MB
BIT Annual report and Notice of Annual General Meeting-BIT.AX
17/10/16 download Created with Sketch. 894.71KB
BIT Appendix 4C - quarterly-BIT.AX
17/10/16PRICE SENSITIVE download Created with Sketch. 82.17KB
BIT Change of Director's Interest Notice-BIT.AX
05/10/16 download Created with Sketch. 41.02KB
BIT Appendix 3B-BIT.AX
05/10/16 download Created with Sketch. 111.3KB
BIT Clarification Statement-BIT.AX
05/09/16 download Created with Sketch. 43.93KB
BIT Option Expiry Notice-BIT.AX
02/09/16 download Created with Sketch. 106.54KB
BIT Zika Virus Program Update-BIT.AX
22/08/16PRICE SENSITIVE download Created with Sketch. 79.6KB
BIT Full Year Statutory Accounts-BIT.AX
05/08/16PRICE SENSITIVE download Created with Sketch. 428.34KB
BIT Appendix 4G and Corporate Governance Statement-BIT.AX
05/08/16 download Created with Sketch. 239.8KB
BIT Appendix 3B-BIT.AX
15/07/16 download Created with Sketch. 59.08KB
BIT Appendix 4C - quarterly-BIT.AX
08/07/16PRICE SENSITIVE download Created with Sketch. 22.67KB
BIT Appendix 3B-BIT.AX
07/07/16 download Created with Sketch. 59.09KB
BIT Biotron compounds demonstrate activity against Zika virus-BIT.AX
23/05/16PRICE SENSITIVE download Created with Sketch. 98.76KB
BIT Presentation at Biotech Invest 2016-BIT.AX
04/05/16 download Created with Sketch. 1.12MB
BIT $1.5 Million R&D Tax Rebate-BIT.AX
20/04/16PRICE SENSITIVE download Created with Sketch. 34.13KB
BIT Appendix 4C - quarterly-BIT.AX
20/04/16PRICE SENSITIVE download Created with Sketch. 22.69KB
BIT Letter to Shareholders-BIT.AX
12/04/16 download Created with Sketch. 239.67KB
BIT Phase 2 Hepatitis C Trial Success
17/03/16PRICE SENSITIVE download Created with Sketch. 26.86KB
BIT Half Yearly Report and Accounts
26/02/16PRICE SENSITIVE download Created with Sketch. 107.47KB
BIT BIT225 MAY HAVE A BROADER ROLE IN LIMITING HIV-1 INFECTION
18/02/16PRICE SENSITIVE download Created with Sketch. 36.42KB
BIT BIOTRON COMPOUNDS TESTED FOR ACTIVITY AGAINST ZIKA VIRUS
16/02/16PRICE SENSITIVE download Created with Sketch. 22.68KB
BIT Appendix 4C - quarterly
15/01/16PRICE SENSITIVE download Created with Sketch. 22.71KB
BIT Appendix 3B
15/01/16 download Created with Sketch. 59.08KB
BIT BIOTRON LIMITED PRESENTS AT BIOTECH SHOWCASE 2016
12/01/16 download Created with Sketch. 3.12MB
BIT POTENTIAL ERADICATION OF HIV RESEVOIRS DATA PUBLISHED
03/12/15 download Created with Sketch. 25.4KB
BIT Grant of Options and Appendices 3B and 3Y
25/11/15 download Created with Sketch. 111.57KB
BIT Results of Meeting
24/11/15 download Created with Sketch. 29.07KB
BIT AGM Presentation
24/11/15 download Created with Sketch. 1.91MB
BIT Appendix 4C - quarterly
22/10/15PRICE SENSITIVE download Created with Sketch. 37.74KB
BIT Annual Report, Governance Statement and Notice of AGM
21/10/15 download Created with Sketch. 757.9KB
BIT Change of Director's Interest Notice
15/10/15 download Created with Sketch. 38.57KB
BIT Presentation to Investors
06/10/15 download Created with Sketch. 524.59KB
BIT Letter to Shareholders
06/10/15 download Created with Sketch. 139.7KB
BIT INTERIM HCV GENOTYPE 3 DATA FROM BIT225-008 STUDY
30/09/15PRICE SENSITIVE download Created with Sketch. 31.61KB
BIT Annual Report to Shareholders
28/08/15PRICE SENSITIVE download Created with Sketch. 363.33KB
BIT Investor Presentation
20/08/15 download Created with Sketch. 1.06MB
BIT Letter to Shareholders
28/07/15 download Created with Sketch. 247.39KB
BIT Cash Flow Report
27/07/15PRICE SENSITIVE download Created with Sketch. 47.21KB
BIT SPP Completed. Appendices 3B and 3Y.
15/07/15 download Created with Sketch. 157.81KB
BIT Independent review supports development of BIT225
06/07/15PRICE SENSITIVE download Created with Sketch. 25.16KB
BIT Appendix 3B
03/07/15 download Created with Sketch. 111.39KB
BIT Appendix 3B
23/06/15 download Created with Sketch. 121.63KB
BIT Share Purchase Plan and Placement to Raise $4.0 Million
18/06/15PRICE SENSITIVE download Created with Sketch. 339.09KB
BIT Trading Halt
16/06/15PRICE SENSITIVE download Created with Sketch. 42.19KB
BIT Presentation to Investors
28/05/15 download Created with Sketch. 1.78MB
BIT Appendix 4C - quarterly
24/04/15PRICE SENSITIVE download Created with Sketch. 37.76KB
BIT R&D Tax Incentive
21/04/15PRICE SENSITIVE download Created with Sketch. 48.72KB
BIT Update on Phase 2 Trial and IND Progress
17/04/15PRICE SENSITIVE download Created with Sketch. 40.79KB
BIT Change of Director's Interest Notice
05/03/15 download Created with Sketch. 38.62KB
BIT Appendix 3B
27/02/15 download Created with Sketch. 59.07KB
BIT Half Yearly Report and Accounts
27/02/15PRICE SENSITIVE download Created with Sketch. 112.08KB
BIT Response to ASX price query
26/02/15PRICE SENSITIVE download Created with Sketch. 111.4KB
BIT Appendix 3B
03/02/15 download Created with Sketch. 59.07KB
BIT Appendix 4C - quarterly
21/01/15PRICE SENSITIVE download Created with Sketch. 37.77KB
BIT BIOTRON LIMITED PRESENTS AT BIOTECH SHOWCASE 2015
13/01/15 download Created with Sketch. 39.26KB
BIT Response to ASX Price Query
08/01/15PRICE SENSITIVE download Created with Sketch. 117.33KB
BIT Appendix 3B
19/12/14 download Created with Sketch. 59.1KB
BIT Details of Share Registry Address
10/12/14 download Created with Sketch. 18.99KB
BIT Presentation to Investors
04/12/14 download Created with Sketch. 2.27MB
BIT Enrolment of Phase 2 Hepatitis C Trial of BIT225 Completed
03/12/14PRICE SENSITIVE download Created with Sketch. 26.74KB
BIT Appendix 3B
03/12/14 download Created with Sketch. 59.09KB
BIT Change of Director's Interest Notice
20/11/14 download Created with Sketch. 39.09KB
BIT Results of Meeting
13/11/14 download Created with Sketch. 28.54KB
BIT Chairman's Address to Shareholders
13/11/14 download Created with Sketch. 2.59MB
BIT Change of Director's Interest Notice
12/11/14 download Created with Sketch. 58.95KB
BIT Fully Underwritten Rights Issue Closes Oversubscribed
05/11/14 download Created with Sketch. 84.35KB
BIT Appendix 4C - quarterly
31/10/14PRICE SENSITIVE download Created with Sketch. 37.7KB
BIT Appendix 3B
15/10/14 download Created with Sketch. 71.2KB
BIT Rights Issue Prospectus
15/10/14PRICE SENSITIVE download Created with Sketch. 1.69MB
BIT Fully Underwritten Rights Issue and Investor Presentation
15/10/14PRICE SENSITIVE download Created with Sketch. 2.31MB
BIT Annual Report and Notice of AGM
14/10/14 download Created with Sketch. 584.46KB
BIT Trading halt
13/10/14PRICE SENSITIVE download Created with Sketch. 46.2KB
BIT BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS C
10/10/14PRICE SENSITIVE download Created with Sketch. 55.29KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $3.318M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
48 38814169 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15608555 20
View Market Depth
Last trade - 09.59am 01/08/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.